KLP Kapitalforvaltning’s KalVista Pharmaceuticals KALV Stock Holding History

KLP Kapitalforvaltning’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,000	Closed	-$121K	–	2176
2026 Q1	$121K	Hold	6,000	–	–	﹤0.01%	2000
2025 Q4	$96.9K	Buy	6,000 +800	+15%	+$10.6K	﹤0.01%	2084
2025 Q3	$63.3K	Buy	+5,200	New	+$71.9K	﹤0.01%	2129

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

KLP Kapitalforvaltning's KALV Position: Q2 2026 in Review

KLP Kapitalforvaltning sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 6,000 shares — an estimated $121K sold.

KLP Kapitalforvaltning first reported a position in KALV in Q3 2025 and held it in 3 quarters. The position peaked at $121K in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

KLP Kapitalforvaltning reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
KLP Kapitalforvaltning sold 6,000 KalVista Pharmaceuticals shares in Q2 2026, an estimated $121K.
KLP Kapitalforvaltning first reported a position in KalVista Pharmaceuticals in Q3 2025 and held it in 3 quarters.
KLP Kapitalforvaltning's KalVista Pharmaceuticals position peaked at $121K in Q1 2026.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.